PHAR vs CAC

Comparison between Pharming Group N.V. (PHAR, Company) and Camden National Corp (CAC, Company).

PHAR is from the Healthcare sector, while CAC is from the Financial Services sector.

5-Year PerformanceCAC has outperformed PHAR, delivering a return of +8.1% compared to +2.9%

PHAR vs CAC - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	PHAR(COMPANY)	CAC(COMPANY)
Market Cap	$909M	$907M
Max Drawdown	60.45%	66.92%
Sharpe Ratio	0.73	0.95
5Y Beta	0.63	0.82
Industry	Biotechnology	Banks - Regional
P/E Ratio	72.56	11.38
Forward P/E	23.09	10.25
PEG Ratio	N/A	0.23
Dividend Yield	N/A	3.10%
5Y Dividends CAGR	N/A	8.76%
5Y EPS CAGR	-19.96%	1.36%
Debt to Equity	43.21%	72.31%
Free Cash Flow Yield	5.51%	8.51%
P/S Ratio	2.48	3.68
P/B Ratio	3.45	1.29

Market Cap

Winner

PHAR

$909M

CAC

$907M

Max Drawdown

Winner

PHAR

60.45%

CAC

66.92%

Sharpe Ratio

PHAR

0.73

Winner

CAC

0.95

5Y Beta

Winner

PHAR

0.63

CAC

0.82

Industry

PHAR

Biotechnology

CAC

Banks - Regional

P/E Ratio

PHAR

72.56

Winner

CAC

11.38

Forward P/E

PHAR

23.09

Winner

CAC

10.25

PEG Ratio

PHAR

N/A

CAC

0.23

Dividend Yield

PHAR

N/A

CAC

3.10%

5Y Dividends CAGR

PHAR

N/A

CAC

8.76%

5Y EPS CAGR

PHAR

-19.96%

Winner

CAC

1.36%

Debt to Equity

Winner

PHAR

43.21%

CAC

72.31%

Free Cash Flow Yield

PHAR

5.51%

Winner

CAC

8.51%

P/S Ratio

Winner

PHAR

2.48

CAC

3.68

P/B Ratio

PHAR

3.45

Winner

CAC

1.29

PHAR vs CAC - Historical Returns

Returns include dividend reinvestment.

Period	PHAR	CAC
1 month	+2.33%	+2.34%
3 months	-20.85%	+8.29%
6 months	-33.15%	+19.55%
1 year	+30.40%	+32.77%
5 years(CAGR)	+2.89%	+8.15%
10 years(CAGR)	N/A	+9.87%
Max(CAGR)	-4.17%	+9.09%

PHAR

+2.33%

Winner

CAC

+2.34%

PHAR

-20.85%

Winner

CAC

+8.29%

PHAR

-33.15%

Winner

CAC

+19.55%

PHAR

+30.40%

Winner

CAC

+32.77%

5Y(CAGR)

PHAR

+2.89%

Winner

CAC

+8.15%

10Y(CAGR)

PHAR

N/A

CAC

+9.87%

Max(CAGR)

PHAR

-4.17%

Winner

CAC

+9.09%

PHAR vs CAC - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	PHAR	CAC
2026	-23.16%	+27.74%
2025	+68.93%	+7.08%
2024	-12.49%	+18.51%
2023	-0.70%	-5.35%
2022	+24.49%	-12.38%
2021	-40.08%	+38.17%
2020	-9.01%	-19.25%
2019	N/A	+30.40%
2018	N/A	-12.99%
2017	N/A	-2.16%
2016	N/A	+58.32%
2015	N/A	+16.15%
2014	N/A	-0.53%
2013	N/A	+17.07%
2012	N/A	+0.50%
2011	N/A	-9.19%
2010	N/A	+11.32%
2009	N/A	+27.52%
2008	N/A	-0.97%
2007	N/A	-35.95%
2006	N/A	+44.43%
2005	N/A	-14.84%
2004	N/A	+34.42%
2003	N/A	+27.06%
2002	N/A	+34.76%
2001	N/A	+45.65%
2000	N/A	-8.52%
1999	N/A	-11.84%

PHAR vs CAC Drawdown Comparison

The maximum drawdown for PHAR was -60.45%, occurring on Jun 16, 2022. Recovery took 1225 trading sessions.

The maximum drawdown for CAC was -64.60%, occurring on Mar 9, 2009. Recovery took 1388 trading sessions.

The current PHAR drawdown is -37.82%. The current CAC drawdown is -3.58%.

Rank	PHAR	CAC
#1	-60.45% Dec 23, 2020 - Nov 10, 2025	-64.60% Dec 28, 2006 - Jul 3, 2012
#2	-43.34% Jan 27, 2026 - May 7, 2026	-43.56% Jan 7, 2022 - Nov 6, 2024
#3	-10.93% Nov 26, 2025 - Dec 12, 2025	-43.46% Feb 5, 2020 - Mar 8, 2021
#4	-10.03% Nov 10, 2025 - Nov 13, 2025	-37.51% Nov 5, 1999 - Jul 31, 2001
#5	-9.70% Nov 13, 2025 - Nov 26, 2025	-27.22% Jun 21, 2018 - May 3, 2019
#6	-9.45% Dec 12, 2025 - Dec 24, 2025	-25.97% Nov 6, 2024 - Jan 21, 2026
#7	-7.08% Dec 24, 2025 - Jan 9, 2026	-22.20% Dec 14, 2004 - Aug 2, 2005
#8	-4.58% Jan 12, 2026 - Jan 22, 2026	-21.61% Jun 24, 2002 - Jun 30, 2003
#9	-1.15% Jan 22, 2026 - Jan 26, 2026	-20.69% Jul 3, 2012 - Jul 16, 2013
#10	N/A	-19.83% Nov 29, 2013 - Nov 3, 2015
#11	N/A	-18.69% Aug 9, 2001 - Jan 7, 2002
#12	N/A	-17.50% Sep 12, 2005 - Apr 21, 2006
#13	N/A	-16.39% Dec 7, 2015 - Jul 13, 2016
#14	N/A	-16.25% Mar 5, 2004 - Sep 28, 2004
#15	N/A	-16.15% Dec 21, 2016 - Oct 20, 2017